Announcement under Regulation 30 (LODR)-Acquisition
We would like to inform that the Company has signed share purchase agreement jointly with Zydus Wellness Limited for proposed acquisition of 100% equity share capital of Heinz India Private Limited. Zydus Cadila gets USFDA nod to market generic seizures treatment drug
Drug firm Zydus Cadila on Tuesday said it has received final nod from the US health regulator to market generic Clobazam tablets used for treatment o Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose herewith a copy of press release dated October 23, 2018 titled 'Zydus receives final approval from the USFDA for Clobazam Tablets'. Board Meeting Intimation for Approval Of Half Yearly Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2018.
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2018 ,inter alia, to consider and approve The meeting of the Board of Directors of the Company will be held on Saturday, November 3, 2018 to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2018. Further, as per code of conduct for prevention of Insider... Zydus Cadila gets USFDA nod for generic gout attacks drug
Drug firm Zydus Cadila Thursday said it has received a tentative nod to market generic Colchicine tablets used for prevention and treatment of gout a Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Colchicine Tablets Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Clobetasol Propionate Cream Zydus Cadila gets tentative USFDA nod for diabetes drug
Drug firm Zydus Cadila on Friday said it has received tentative approval from the US health regulator to market Linagliptin and Metformin Hydrochlori Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose herewith a copy of press release dated October 12, 2018 titled 'Zydus receives tentative approval from the USFDA for Linagliptin and Metformin Hydrochloride Tablets'. Shareholding for the Period Ended September 30, 2018
Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here